The FNAIT Journey: Living
Find out what’s new and what’s next in treatment options for FNAIT.
-
-
New method may help predict platelet transfusion risk in infants
-
Antibodies differ in patients with platelet transfusion refractoriness
-
Researchers identify potential treatment for neonatal brain bleed
-
Clinical trial to test nipocalimab vs IVIG to prevent FNAIT
-
Immune thrombocytopenia in late pregnancy requires specialized care
-
Alloimmunization risk factors include genetics and immune system
